【4521】科研製薬
製薬。関節機能改善剤。
業績予想修正履歴
決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025.03 | 2024/08/07 | 修正予 | 88,500 | ↑ | +17.8% | +17.8% | 20,800 | ↑ | +181.1% | +181.1% | 21,200 | ↑ | +171.8% | +171.8% | 14,200 | ↑ | +153.6% | +153.6% |
2025.03 | 2024/05/14 | 当初予 | 75,100 | - | - | - | 7,400 | - | - | - | 7,800 | - | - | - | 5,600 | - | - | - |
2024.03 | 2024/05/14 | 実 | 72,044 | ↓ | -1.4% | -1.4% | 9,513 | ↑ | +25.2% | +25.2% | 9,951 | ↑ | +24.4% | +24.4% | 8,025 | ↑ | +19.8% | +19.8% |
2024.03 | 2024/02/06 | Q3予 | 73,100 | → | 0.0% | 0.0% | 7,600 | → | 0.0% | 0.0% | 8,000 | → | 0.0% | 0.0% | 6,700 | → | 0.0% | 0.0% |
2024.03 | 2023/11/08 | Q2予 | 73,100 | → | 0.0% | 0.0% | 7,600 | → | 0.0% | 0.0% | 8,000 | → | 0.0% | 0.0% | 6,700 | → | 0.0% | 0.0% |
2024.03 | 2023/08/04 | Q1予 | 73,100 | → | 0.0% | 0.0% | 7,600 | → | 0.0% | 0.0% | 8,000 | → | 0.0% | 0.0% | 6,700 | → | 0.0% | 0.0% |
2024.03 | 2023/05/10 | 当初予 | 73,100 | - | - | - | 7,600 | - | - | - | 8,000 | - | - | - | 6,700 | - | - | - |
2023.03 | 2023/05/10 | 実 | 72,984 | ↓ | -0.7% | -4.5% | 7,998 | ↑ | +6.6% | -46.7% | 8,727 | ↑ | +7.7% | -43.7% | 5,440 | ↓ | -10.8% | -54.7% |
2023.03 | 2023/02/03 | Q3予 | 73,500 | ↓ | -3.8% | -3.8% | 7,500 | ↓ | -50.0% | -50.0% | 8,100 | ↓ | -47.7% | -47.7% | 6,100 | ↓ | -49.2% | -49.2% |
2023.03 | 2022/11/08 | Q2予 | 76,400 | → | 0.0% | 0.0% | 15,000 | → | 0.0% | 0.0% | 15,500 | → | 0.0% | 0.0% | 12,000 | → | 0.0% | 0.0% |
2023.03 | 2022/08/03 | Q1予 | 76,400 | → | 0.0% | 0.0% | 15,000 | → | 0.0% | 0.0% | 15,500 | → | 0.0% | 0.0% | 12,000 | → | 0.0% | 0.0% |
2023.03 | 2022/05/11 | 当初予 | 76,400 | - | - | - | 15,000 | - | - | - | 15,500 | - | - | - | 12,000 | - | - | - |
2022.03 | 2022/05/11 | 実 | 76,034 | ↑ | +0.0% | -4.0% | 17,064 | ↑ | +3.4% | -9.2% | 17,542 | ↑ | +3.2% | -8.6% | 9,549 | ↑ | +3.8% | -31.8% |
2022.03 | 2022/03/29 | 修正予 | 76,000 | ↓ | -4.0% | -4.0% | 16,500 | ↓ | -12.2% | -12.2% | 17,000 | ↓ | -11.5% | -11.5% | 9,200 | ↓ | -34.3% | -34.3% |
2022.03 | 2022/02/03 | Q3予 | 79,200 | → | 0.0% | 0.0% | 18,800 | → | 0.0% | 0.0% | 19,200 | → | 0.0% | 0.0% | 14,000 | → | 0.0% | 0.0% |
2022.03 | 2021/11/04 | Q2予 | 79,200 | → | 0.0% | 0.0% | 18,800 | → | 0.0% | 0.0% | 19,200 | → | 0.0% | 0.0% | 14,000 | → | 0.0% | 0.0% |
2022.03 | 2021/08/03 | Q1予 | 79,200 | → | 0.0% | 0.0% | 18,800 | → | 0.0% | 0.0% | 19,200 | → | 0.0% | 0.0% | 14,000 | → | 0.0% | 0.0% |
2022.03 | 2021/05/07 | 当初予 | 79,200 | - | - | - | 18,800 | - | - | - | 19,200 | - | - | - | 14,000 | - | - | - |
2021.03 | 2021/05/07 | 実 | 74,979 | ↓ | -2.9% | -9.6% | 17,788 | ↓ | -1.7% | -14.5% | 18,222 | ↓ | -1.5% | -14.0% | 13,405 | ↑ | +0.0% | -10.6% |
2021.03 | 2021/02/03 | Q3予 | 77,200 | → | 0.0% | -6.9% | 18,100 | → | 0.0% | -13.0% | 18,500 | → | 0.0% | -12.7% | 13,400 | → | 0.0% | -10.7% |
2021.03 | 2020/11/05 | Q2予 | 77,200 | → | 0.0% | -6.9% | 18,100 | → | 0.0% | -13.0% | 18,500 | → | 0.0% | -12.7% | 13,400 | → | 0.0% | -10.7% |
2021.03 | 2020/10/27 | 修正予 | 77,200 | ↓ | -6.9% | -6.9% | 18,100 | ↓ | -13.0% | -13.0% | 18,500 | ↓ | -12.7% | -12.7% | 13,400 | ↓ | -10.7% | -10.7% |
2021.03 | 2020/08/03 | 修正予 | 82,900 | - | - | - | 20,800 | - | - | - | 21,200 | - | - | - | 15,000 | - | - | - |
2020.03 | 2020/03/27 | 修正予 | 89,000 | ↓ | -4.2% | -4.2% | 26,000 | ↑ | +16.6% | +16.6% | 26,400 | ↑ | +16.3% | +16.3% | 18,600 | ↑ | +15.5% | +15.5% |
2020.03 | 2020/02/03 | Q3予 | 92,900 | → | 0.0% | 0.0% | 22,300 | → | 0.0% | 0.0% | 22,700 | → | 0.0% | 0.0% | 16,100 | → | 0.0% | 0.0% |
2020.03 | 2019/11/06 | Q2予 | 92,900 | → | 0.0% | 0.0% | 22,300 | → | 0.0% | 0.0% | 22,700 | → | 0.0% | 0.0% | 16,100 | → | 0.0% | 0.0% |
2020.03 | 2019/08/01 | Q1予 | 92,900 | → | 0.0% | 0.0% | 22,300 | → | 0.0% | 0.0% | 22,700 | → | 0.0% | 0.0% | 16,100 | → | 0.0% | 0.0% |
2020.03 | 2019/05/09 | 当初予 | 92,900 | - | - | - | 22,300 | - | - | - | 22,700 | - | - | - | 16,100 | - | - | - |
2019.03 | 2019/05/09 | 実 | 94,165 | ↓ | -0.7% | -0.7% | 24,592 | ↑ | +9.3% | +9.3% | 24,972 | ↑ | +9.5% | +9.5% | 17,775 | ↑ | +8.4% | +8.4% |
2019.03 | 2019/02/01 | Q3予 | 94,800 | → | 0.0% | 0.0% | 22,500 | → | 0.0% | 0.0% | 22,800 | → | 0.0% | 0.0% | 16,400 | → | 0.0% | 0.0% |
2019.03 | 2018/11/06 | Q2予 | 94,800 | → | 0.0% | 0.0% | 22,500 | → | 0.0% | 0.0% | 22,800 | → | 0.0% | 0.0% | 16,400 | → | 0.0% | 0.0% |
2019.03 | 2018/08/01 | Q1予 | 94,800 | → | 0.0% | 0.0% | 22,500 | - | - | - | 22,800 | → | 0.0% | 0.0% | 16,400 | → | 0.0% | 0.0% |
2019.03 | 2018/05/09 | 当初予 | 94,800 | - | - | - | - | - | - | - | 22,800 | - | - | - | 16,400 | - | - | - |
2018.03 | 2018/05/09 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
2018.03 | 2018/02/01 | Q3予 | 101,700 | → | 0.0% | 0.0% | 26,800 | → | 0.0% | 0.0% | 27,000 | → | 0.0% | 0.0% | 19,100 | → | 0.0% | 0.0% |
2018.03 | 2017/11/06 | Q2予 | 101,700 | → | 0.0% | 0.0% | 26,800 | → | 0.0% | 0.0% | 27,000 | → | 0.0% | 0.0% | 19,100 | → | 0.0% | 0.0% |
2018.03 | 2017/08/01 | Q1予 | 101,700 | → | 0.0% | 0.0% | 26,800 | → | 0.0% | 0.0% | 27,000 | → | 0.0% | 0.0% | 19,100 | → | 0.0% | 0.0% |
2018.03 | 2017/05/10 | 当初予 | 101,700 | - | - | - | 26,800 | - | - | - | 27,000 | - | - | - | 19,100 | - | - | - |
2017.03 | 2017/05/10 | 実 | 101,479 | ↑ | +0.2% | -4.4% | 30,707 | ↑ | +0.3% | +6.3% | 30,981 | ↑ | +0.3% | +6.5% | 22,017 | ↑ | +1.0% | +5.9% |
2017.03 | 2017/03/28 | 修正予 | 101,300 | ↓ | -4.5% | -4.5% | 30,600 | ↑ | +5.9% | +5.9% | 30,900 | ↑ | +6.2% | +6.2% | 21,800 | ↑ | +4.8% | +4.8% |
2017.03 | 2017/02/06 | Q3予 | 106,100 | → | 0.0% | 0.0% | 28,900 | → | 0.0% | 0.0% | 29,100 | → | 0.0% | 0.0% | 20,800 | → | 0.0% | 0.0% |
2017.03 | 2016/11/07 | Q2予 | 106,100 | → | 0.0% | 0.0% | 28,900 | → | 0.0% | 0.0% | 29,100 | → | 0.0% | 0.0% | 20,800 | → | 0.0% | 0.0% |
2017.03 | 2016/08/03 | Q1予 | 106,100 | → | 0.0% | 0.0% | 28,900 | → | 0.0% | 0.0% | 29,100 | → | 0.0% | 0.0% | 20,800 | → | 0.0% | 0.0% |
2017.03 | 2016/05/12 | 当初予 | 106,100 | - | - | - | 28,900 | - | - | - | 29,100 | - | - | - | 20,800 | - | - | - |
2016.03 | 2016/05/12 | 実 | 109,730 | ↑ | +1.7% | +11.4% | 35,146 | ↑ | +9.1% | +67.4% | 35,365 | ↑ | +9.2% | +67.6% | 21,143 | ↑ | +10.1% | +51.0% |
2016.03 | 2016/02/05 | Q3予 | 107,900 | → | 0.0% | +9.5% | 32,200 | → | 0.0% | +53.3% | 32,400 | → | 0.0% | +53.6% | 19,200 | → | 0.0% | +37.1% |
2016.03 | 2015/11/06 | Q2予 | 107,900 | → | 0.0% | +9.5% | 32,200 | → | 0.0% | +53.3% | 32,400 | → | 0.0% | +53.6% | 19,200 | → | 0.0% | +37.1% |
2016.03 | 2015/10/27 | 修正予 | 107,900 | ↑ | +9.5% | +9.5% | 32,200 | ↑ | +53.3% | +53.3% | 32,400 | ↑ | +53.6% | +53.6% | 19,200 | ↑ | +37.1% | +37.1% |
2016.03 | 2015/08/05 | Q1予 | 98,500 | → | 0.0% | 0.0% | 21,000 | → | 0.0% | 0.0% | 21,100 | → | 0.0% | 0.0% | 14,000 | → | 0.0% | 0.0% |
2016.03 | 2015/05/12 | 当初予 | 98,500 | - | - | - | 21,000 | - | - | - | 21,100 | - | - | - | 14,000 | - | - | - |
2015.03 | 2015/05/12 | 実 | 93,889 | ↓ | -0.0% | +2.7% | 20,631 | ↑ | +0.2% | +22.8% | 20,394 | ↑ | +0.5% | +24.4% | 12,122 | ↑ | +2.7% | +13.3% |
2015.03 | 2015/03/26 | 修正予 | 93,900 | ↑ | +2.7% | +2.7% | 20,600 | ↑ | +22.6% | +22.6% | 20,300 | ↑ | +23.8% | +23.8% | 11,800 | ↑ | +10.3% | +10.3% |
2015.03 | 2015/02/05 | Q3予 | 91,400 | → | 0.0% | 0.0% | 16,800 | → | 0.0% | 0.0% | 16,400 | → | 0.0% | 0.0% | 10,700 | → | 0.0% | 0.0% |
2015.03 | 2014/11/06 | Q2予 | 91,400 | → | 0.0% | 0.0% | 16,800 | → | 0.0% | 0.0% | 16,400 | → | 0.0% | 0.0% | 10,700 | → | 0.0% | 0.0% |
2015.03 | 2014/08/05 | Q1予 | 91,400 | → | 0.0% | 0.0% | 16,800 | → | 0.0% | 0.0% | 16,400 | → | 0.0% | 0.0% | 10,700 | → | 0.0% | 0.0% |
2015.03 | 2014/05/12 | 当初予 | 91,400 | - | - | - | 16,800 | - | - | - | 16,400 | - | - | - | 10,700 | - | - | - |
2014.03 | 2014/05/12 | 実 | 88,946 | - | - | - | 15,872 | - | - | - | 15,521 | - | - | - | 9,735 | - | - | - |